Jason Butch - Net Worth and Insider Trading
Jason Butch Net Worth
The estimated net worth of Jason Butch is at least $4 dollars as of 2024-06-08. Jason Butch is the Principal Accounting Officer of Agile Therapeutics Inc and owns about 10 shares of Agile Therapeutics Inc (AGRX) stock worth over $4. Details can be seen in Jason Butch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Butch has not made any transactions after 2021-03-29 and currently still holds the listed stock(s).
Transaction Summary of Jason Butch
Jason Butch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Butch owns 1 companies in total, including Agile Therapeutics Inc (AGRX) .
Click here to see the complete history of Jason Butch’s form 4 insider trades.
Insider Ownership Summary of Jason Butch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2021-03-29 | Principal Accounting Officer |
Jason Butch Latest Holdings Summary
Jason Butch currently owns a total of 1 stock. Jason Butch owns 10 shares of Agile Therapeutics Inc (AGRX) as of March 29, 2021, with a value of $4.
Latest Holdings of Jason Butch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2021-03-29 | 10 | 0.37 | 4 |
Holding Weightings of Jason Butch
Jason Butch Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Butch has made a total of 1 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Agile Therapeutics Inc is the acquisition of 5 shares on March 29, 2021, which cost Jason Butch around $20,100.
Insider Trading History of Jason Butch
- 1
Jason Butch Trading Performance
GuruFocus tracks the stock performance after each of Jason Butch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Butch is -29.08%. GuruFocus also compares Jason Butch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Butch within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Butch's insider trading performs compared to the benchmark.
Performance of Jason Butch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.14 | | | | | |
| Relative Return to S&P 500(%) | -13.19 | | | | | |
Jason Butch Ownership Network
Jason Butch Owned Company Details
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Jason Butch is the Principal Accounting Officer of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
Jason Butch Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Butch. You might contact Jason Butch via mailing address: 101 Poor Farm Road, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
